 |
| Global Stem Cell Therapy Market Size |
Stem cell therapy involves the use of stem cells and their derivatives to treat
diseases including damaged organs, tissues or neurological disorders. Stem
cells have the unique ability to replicate repeatedly and differentiate into
various cell types. Researchers hope stem cell therapies could help repair
damaged organs or tissue and treat conditions such as leukemia, diabetes, heart
disease and neurodegenerative disorders. The global stem cell therapy market is
witnessing strong growth due to the increasing prevalence of chronic diseases
and growing awareness about the potential of stem cell treatments.
The global
stem cell therapy Market is estimated to be valued at US$ 54.14 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
One of the key trends driving growth in the stem cell therapy market is the
increasing adoption rates among patients and clinicians alike. As research
continues to demonstrate the clinical benefits of stem cell therapies for
various hard-to-treat conditions, adoption is accelerating. Increased awareness
is another important factor, as patients and healthcare providers become more
knowledgeable about this cutting-edge treatment option. This has made stem cell
therapies an increasingly viable alternative or complement to traditional
medicine. The higher adoption rates will be a major factor propelling the stem
cell therapy market forward over the coming years.
Segment Analysis
The global stem cell therapy market is primarily segmented into Allogeneic stem
cell therapy and Autologous stem cell therapy. Allogeneic stem cell therapy
dominates the market and accounts for over 60% market share. This is because
allogeneic stem cell therapy does not require harvesting stem cells from
patient's own body, making the process less complex and time-consuming as
compared to autologous stem cell therapy.
Key Takeaways
Global
Stem Cell Therapy Market Size is expected to witness high growth over
the forecast period of 2023 to 2030. The global stem cell therapy Market is
estimated to be valued at US$ 54.14 Mn in
2023 and is expected to exhibit a CAGR
of 5.4% over the forecast period 2023 to 2030.
North
America dominated the market with over 35% market share in 2023 due to presence
of advanced healthcare facilities and increasing investments in stem cell
research in the region. Europe is the second largest and fastest growing market
for stem cell therapy owing to rising government funding for stem cell
research. Asia Pacific is expected to witness highest growth during the
forecast period. This is attributed to increasing healthcare expenditure,
rising medical tourism, and growing geriatric population in countries like
China and India. Moreover, improving research infrastructure and loosening
regulatory restrictions will further aid market growth in the region.
Key players related content comprises
Key players operating in the stem cell therapy market are Mars Inc., Nestle SA
(Purina), Church & Dwight Co Inc., The Clorox Company, Dr. Elsey’s, Oil-Dri
Corporation of America, Pestell Pet Products, Zolux Sas, Cat Litter Company,
and Healthy Pet. Mars Inc. and Nestle SA (Purina) dominate the market with
their wide range of stem cell therapy products for pets.
Explore More Related Article On This
Topic: https://www.pressreleasebulletin.com/stem-cell-therapy-market-share/
Explore More Related Article On This
Topic: https://filmik.in/cracking-the-code-of-epigenetics-the-harmony-of-gene-expression-outside-of-dna/